Core Insights - Ageas reported strong financial results for the full year 2025, highlighting a transformational year for the company [1][2] - The company achieved a 9% increase in inflows, with a notable 33% rise in net operating results, reaching EUR 1.65 billion [1][2] - Ageas proposed a gross cash dividend of EUR 3.75, reflecting its commitment to shareholders [1][2] Financial Performance - Total inflows reached EUR 19.6 billion, marking a 9% increase compared to 2024 [1] - The net operating result was EUR 1.65 billion, up 33% from the previous year [1] - Free cash flow amounted to EUR 774 million, representing a 19% increase year-over-year [1] - The proposed gross cash dividend for 2025 is EUR 3.75, a 7% increase from 2024 [1] Strategic Developments - The acquisition of esure positioned Ageas as the 3rd largest personal lines insurer in the UK, while full ownership of Belgium's leading insurer AG was secured [2] - The Elevate27 strategy gained momentum, allowing the company to raise financial targets twice during the year [2] - Key strategic initiatives included a focus on ageing, SMEs, and enhanced use of Data & AI [2] Sustainability and ESG Performance - Ageas made significant progress in sustainability, earning positive recognition from employees and customers [2] - The company ranks in the top quartile with three of the five ESG rating agencies it engages with [2] - The portfolio of sustainable products continued to grow, reflecting the trust of customers and employees [2]

Core Insights - Bureau Veritas achieved sector-leading organic revenue growth of 6.5% in FY 2025, with a strong margin improvement to 16.3% [1][4][10] - The company has a positive growth outlook for 2026, expecting continued margin expansion and a new EUR 200 million share buyback program [1][4][8] Financial Performance - Full-year revenue reached EUR 6,466.4 million, up 6.5% organically, with Q4 organic growth at 6.3% [4][9][40] - Adjusted operating profit increased to EUR 1,052.9 million, a 5.7% rise from EUR 996.2 million in FY 2024, with an adjusted operating margin of 16.3% [4][9][37] - Adjusted net profit was EUR 631.4 million, up 1.7% from EUR 620.7 million in FY 2024, with adjusted EPS at EUR 1.42, reflecting a 2.8% increase [4][9][47] - Free cash flow totaled EUR 824.2 million, a 3.9% organic increase, with cash conversion at 107% [4][9][50] Strategic Developments - The company executed nine bolt-on acquisitions in 2025, contributing EUR 96 million in annualized revenue, while also divesting two non-core activities [4][20][21] - The LEAP I 28 strategy is progressing, with a focus on enhancing operational leverage and functional scalability [4][5][20] - A new organizational structure was implemented to accelerate strategy execution and improve alignment across geographic platforms [4][26][28] Market Trends and Growth Drivers - Strong organic growth was driven by increased energy investments, digital infrastructure development, and demand for corporate risk assessment solutions [4][10][20] - The Americas region saw organic revenue growth of 4.0%, Europe at 4.1%, Asia-Pacific at 8.2%, and the Middle East & Africa at 16.6% [4][40] Shareholder Returns - Bureau Veritas achieved double-digit shareholder returns, supported by a 9% EPS growth at constant currency and a proposed dividend of EUR 0.92 per share, up 2.2% year-on-year [4][13][14] - The new EUR 200 million share buyback program represents approximately 1.5% of outstanding share capital [4][8][13]

Core Insights - The Hangzhou Municipal Government has approved new station names for Metro Line 10 and the Hangzhou-Deqing Intercity Railway, enhancing regional connectivity and industrial development [1] - Yuhang Economic Development Zone is positioned as a key industrial platform in Hangzhou, focusing on smart manufacturing and attracting various industries [3][5] Group 1: Transportation and Infrastructure - Two stations in Yuhang Economic Development Zone have been renamed to reflect their significance in regional transportation: Renhe South Station is now "Dongshanyang Station," and Renhe North Station is "Qihang Road Station" [1] - Qihang Road Station serves as the northern terminus of Metro Line 10's extension and a critical transfer hub for the Hangzhou-Deqing Intercity Railway, enhancing connectivity between Hangzhou and surrounding areas [1] Group 2: Economic Development Zone Overview - Yuhang Economic Development Zone is strategically located in the Yangtze River Delta, providing exceptional geographical advantages and access to major transportation routes [3] - The zone emphasizes smart manufacturing, focusing on new equipment, new materials, and new energy, forming a "One Smart, Three New" industrial system [5] Group 3: Innovation and Research - The zone has partnered with Zhejiang University to establish the Advanced Electrical Equipment Innovation Center, which focuses on research in new energy vehicle systems and intelligent robotics [6] - Over 570,000 square meters of incubation space are available, supporting the growth of enterprises at all stages [6] Group 4: Supportive Policies - Yuhang Economic Development Zone offers substantial support policies for attracting global resources, including equipment subsidies and R&D grants for eligible projects [7] - Specific incentives are provided for integrated circuit and robotics enterprises, promoting industry growth [7] Group 5: Comprehensive Development - The zone is advancing its development philosophy of enhancing the environment, technology, and smart manufacturing to support industrial upgrading [8] - Educational, medical, and residential amenities are being developed to support talent and enterprises, including schools and commercial complexes [8] Group 6: Future Outlook - Yuhang Economic Development Zone aims to enhance its smart manufacturing capabilities and achieve national-level economic and technological development status through continuous improvements in its ecosystem and business environment [9]

Core Insights - NORBIT is in advanced negotiations for a contract manufacturing order valued at approximately NOK 115 million with a European client in the defence and security sector, expected to be delivered in Q2 2026 [1] - The company recently received another order worth approximately NOK 80 million for deliveries in the same quarter, indicating strong demand in the defence and security market [1] Industry Context - The defence and security market is experiencing strong activity, with a short delivery window once contracts are awarded, necessitating preparedness and scalable capacity [2] - Agility and trust are essential for successful partnerships in this market, and the company emphasizes its role in enhancing security and resilience [2] Company Overview - NORBIT is a global provider of tailored technology, structured into three business segments: Oceans, Connectivity, and Product Innovation & Realization [3] - The Oceans segment focuses on technology solutions for maritime markets, Connectivity provides wireless solutions for identification and tracking, and Product Innovation & Realization offers R&D services and contract manufacturing [3] - The company is headquartered in Trondheim, employs around 700 people, and has manufacturing capabilities in Europe and North America [3]

Core Viewpoint - Vopak has announced a multi-year share buyback program of up to EUR 500 million, with the first tranche of up to EUR 100 million set to commence on 26 February 2026 [1][3]. Group 1: Share Buyback Program - The multi-year share buyback program is part of a broader shareholder distribution initiative totaling around EUR 1.7 billion through year-end 2030 [2]. - The first tranche of the share buyback program will run from 26 February 2026 to no later than 26 February 2027, subject to board and shareholder approvals [3]. - The share buyback will be executed under the safe harbour regime of the Market Abuse Regulation and within the limits of existing authority granted at the 2025 Annual General Meeting [3]. Group 2: Dividend Policy - Vopak has enhanced its progressive dividend policy, aiming to increase its dividend per share by 5% or more annually [2]. Group 3: Execution and Oversight - The share buyback program will be conducted by an independent intermediary, allowing for open market transactions during both open and closed periods [4]. - There are no agreements with existing shareholders regarding their participation in the share buyback program, which is separate from any share transactions related to long-term incentive programs for employees [4]. Group 4: Communication and Updates - Vopak will provide weekly updates on the progress of the share buyback program through press releases and transaction details on its website [5].

Core Insights - Martela Corporation reported an increase in revenue for the year 2025, with total revenue reaching EUR 93.7 million, an 8.1% increase from EUR 86.7 million in 2024 [10][18]. - The operating result for the year was a loss of EUR -1.1 million, although there was a slight profit of EUR 0.1 million in the fourth quarter [11][12]. - The company anticipates a slight decrease in revenue for the full year 2026 but expects a comparable operating result to be profitable [4]. Financial Performance - For the fourth quarter of 2025, revenue was EUR 22.8 million, down 8.0% from EUR 24.7 million in the same period of 2024 [5][16]. - The operating result for the fourth quarter was EUR 0.1 million, a significant improvement from a loss of EUR -1.8 million in the previous year [9][12]. - The overall result before taxes for the year was EUR -3.2 million, compared to EUR -8.2 million in 2024 [19]. Market Conditions - The economic environment in the Nordic countries remained challenging throughout 2025, with weak demand impacting procurement decisions [8][15]. - Revenue growth was observed in Finland and other countries, while it decreased in Norway and remained stable in Sweden [10][18]. - The company faced intense competition, which continued to pressure margins [15]. Operational Insights - The improvement in operating results was attributed to higher revenue and cost reductions from efficiency measures implemented during the year [11]. - The company experienced a 12% decrease in total new orders during 2025 compared to the previous year, with unsatisfactory order intake in the second half of the year [10]. - Martela plans to focus on improving operational profitability and enhancing administrative cost efficiency in 2026 [13]. Future Outlook - The company is optimistic about the long-term future, citing positive customer feedback and a slight market recovery as encouraging signs for 2026 [14]. - Martela aims to enhance presence-based work environments to improve productivity, responding to the trend of increased remote work in Finland [14]. - The Board of Directors has proposed no dividend distribution for 2025, reflecting the company's focus on liquidity and operational improvements [24].

Core Insights - Bigbank experienced strong growth and solid profitability at the start of 2026, with significant increases in both loan and deposit portfolios [1][2] Loan Portfolio - The loan portfolio grew by 71 million euros in January, driven primarily by a 62 million euro increase in business loans and a 9 million euro increase in home loans, while consumer loans remained stable [1] - The credit quality of the loan portfolio remained strong, with expected credit losses decreasing to 1.0 million euros, down 0.7 million euros from the previous year, and non-performing exposures accounting for 4.3% of all loan receivables [4][9] Deposit Portfolio - The deposit portfolio saw a robust increase of 112 million euros in January, with savings deposits rising by 62 million euros, term deposits by 46 million euros, and current account balances by 5 million euros [2] Financial Performance - Net interest income for January reached 9.7 million euros, an increase of 1.2 million euros or 14% year-on-year, driven by the expansion of the loan portfolio [3][9] - Total net operating income was 10,529 thousand euros, reflecting a 13% increase compared to January 2025 [8] - Net profit for January was 3.8 million euros, up 0.8 million euros or 25% year-on-year, benefiting from increased net interest income and reduced expected credit losses [6][9] Operational Metrics - The bank employed 655 people at the end of January, with personnel expenses increasing by 0.8 million euros compared to the previous year [5] - The return on equity (ROE) for January was 15.1%, an increase of 1.7 percentage points from the previous year [10]

Core Insights - The year 2025 for TextMagic Group was marked by strategic decisions aimed at enhancing performance and operational efficiency, including the sale of a business line and the liquidation of a subsidiary [1] Financial Performance - In 2025, TextMagic Group generated revenue of €13,549 thousand, a 7% decrease from €14,533 thousand in 2024, primarily due to unfavorable exchange rates [2] - The Group recorded an operating loss of €611 thousand in 2025, compared to an operating profit of €1,844 thousand in 2024, largely due to increased depreciation and amortization expenses [3] - EBITDA for 2025 was €4,902 thousand, down from €5,939 thousand in 2024, with an EBITDA margin of 36% compared to 41% in the previous year [4] - Cash flow from operating activities was €4,085 thousand in 2025, a decrease from €5,761 thousand in 2024, indicating continued strong cash generation capabilities [4][5] Structural Changes - The sale of Edicy OÜ, which operated the Voog website and e-commerce platform, was completed in September 2025 and is classified as a discontinued operation [5] - The Romanian subsidiary TM Marketing Ops SRL was closed in November 2025, with marketing activities to be centralized at the Estonian headquarters to reduce costs and improve efficiency [6] Workforce Adjustments - The TextMagic team was reduced to 43 employees by the end of 2025, down from 79 at the end of 2024, with significant reductions occurring late in the year [7] Future Objectives - For 2026, the Group aims to improve cash flow and profitability while focusing on revenue growth and cost efficiency [8] - A key focus for 2026 will be the transformation of the marketing strategy for the TextMagic platform, emphasizing operational messaging and compliance, with an aim to enhance customer satisfaction and marketing effectiveness [9]

Core Insights - Kaldvik AS reported an operating income of EUR 48.2 million in Q4 2025, an increase from EUR 46.8 million in the previous year [1] - The operating loss before fair value adjustment of biomass and production tax improved to EUR -10.6 million from EUR -17.5 million [1] - The total harvest for Q4 2025 was 7,943 tonnes, up from 6,668 tonnes in Q4 2024 [1] - For the full year 2025, total harvest reached 17,105 tonnes, compared to 14,965 tonnes in 2024 [1] - Kaldvik AS maintains its harvest guidance for 2026 at approximately 17,000 tonnes [1] Financial Reporting - Kaldvik AS publishes full financial statements semi-annually, including half-year and annual reports [2] Webcast Information - A webcast presentation of the Q4 2025 quarterly update is scheduled for 10:00 CET on 25 February 2026, featuring CEO Vidar Aspehaug and CFO Hjalti Hvítklett [3] - The webcast will include a Q&A session and can be accessed online [3]

Core Viewpoint - Bicara Therapeutics Inc. has announced a public offering of 7,175,000 shares at $16.00 per share, aiming to raise approximately $150 million to support its clinical and commercial initiatives for ficerafusp alfa, a bifunctional therapy for solid tumors [1][2]. Group 1: Offering Details - The public offering includes pre-funded warrants for 2,200,000 shares at a price of $15.9999 each, with gross proceeds expected to be around $150 million before expenses [1]. - The offering is set to close on or about February 26, 2026, pending customary closing conditions [1]. - Underwriters have a 30-day option to purchase up to 1,406,250 additional shares at the public offering price [1]. Group 2: Use of Proceeds - Net proceeds will be used to enhance medical and commercial infrastructure for a planned regulatory filing and launch of ficerafusp alfa in the U.S. [2]. - Funds will also support the development of ficerafusp alfa in first-line recurrent/metastatic HPV-negative head and neck squamous cell carcinoma, including a less frequent dosing schedule [2]. - Additional uses include covering manufacturing costs for ongoing drug development and early signal-finding for future indication expansion [2]. Group 3: Company Overview - Bicara Therapeutics is focused on developing bifunctional therapies for solid tumors, with its lead program, ficerafusp alfa, designed to penetrate tumors by overcoming barriers in the tumor microenvironment [6]. - Ficerafusp alfa combines an EGFR-directed monoclonal antibody with a domain that binds to TGF-β, aiming to reverse the fibrotic and immune-excluded tumor microenvironment [6]. - The therapy is being developed for head and neck squamous cell carcinoma and other solid tumor types, addressing significant unmet medical needs [6].